View and vote poster event
Cabrini Research Forum
Learn about the latest research being undertaken at Cabrini and in collaboration with other institutions – vote for your favourite posters to go in the running to win a prize.
Voting is open until 30 November 2024. Everyone is welcome to cast a vote by completing the online form to the right.
The research posters have been categorised based on the topic of research being undertaken. Expand each category below to view the posters and download a PDF to read more about the project. A summary of all poster categories, research titles and the presenting authors can be downloaded below.
Posters Awards, including the People’s Choice Award determined by the voting, and the voter’s prize, will be announced at the December session of the Cabrini Research Sessions being held on Wednesday 4 December 12 – 1 pm. Everyone is welcome to join this online event being hosted in Teams.
2024 Cabrini Research Forum Poster Voting
View the posters by research category
The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601).
– Yoland Antill
Preliminary results from a first-in-human trial of AMT-116, a topoisomerase I inhibitor containing antibody-drug conjugate (ADC), in patients with advanced solid tumours.
– Gary Richardson
MYE Symphony: A first-in-human study to investigate the safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the in vivo mRNA CAR therapy, MT-302, targeting TROP2 in adults with advanced epithelial tumours.
– Gary Richardson
Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: Results from phase 1/2 studies.
– Gary Richardson
A phase 1 / 2, first-in-human, open label, dose-escalation study of TAK-280, an investigational B7-H3 x CD3ε conditional bispecific redirected activation (COBRA) T-cell engager, in adult patients with unresectable, locally advanced or metastatic solid tumours.
– Garry Richardson
A Phase 1b Study to Evaluate HMBD 001 in combination with Docetaxel with or without Cetuximab in participants with advanced squamous non-small cell lung cancers, and HMBD 001 in combination with Cetuximab in participants with advanced squamous cell cancers.
– Gary Richardson
Cross-over adjusted overall survival for Amivantamab plus chemotherapy vs chemotherapy in first-line EGFR Exon-20 insertion NSCLC.
– Gary Richardson
Deciphering improved clinical therapeutic index (TI) of Muzastotug (ADG126), a masked anti-CTLA-4 SAFEbody® over its unmasked form (ADG116) as monotherapy or in combination with anti-PD-1 therapy.
– Gary Richardson
Structured exercise improves fatigue and health-related quality of life in patients with metastatic breast cancer.
– Eva Zopf
Complications of catheter ablation for atrial fibrillation: important differences in patients with heart failure with systolic heart failure.
– Rose Crowley
Diagnosis to ablation time in persistent AF patients in the CAPLA trial: Any time can be a good time to ablate.
– Rose Crowley
Patterns of atrial fibrillation recurrence in patients undergoing catheter ablation for persistent atrial fibrillation: implications for quality of life and health care utilisation.
– Rose Crowley
Persistent atrial fibrillation phenotypes and ablation outcomes: Persistent from outset vs progression from paroxysmal AF.
– Rose Crowley
Incidence of Post operative Atrial Fibrillation in Patients Post Non-cardiac and Non-thoracic Surgery and the utility of Holter Monitors.
– Roopa Das
Arterial switch operation for transposition of the great vessels – what about the coronary arteries?
– Rachel Lim
Relationship between Titin and lifestyle risk factors on incident AF risk among the UK Biobank.
– Louise Segan
Impact of catheter ablation on valvular remodeling in patients with AF with left ventricular systolic dysfunction.
– Louise Segan
WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Ejection Fraction After AF Rhythm Control in AF-mediated Cardiomyopathy – The WITHDRAW-AF Randomized Trial.
– Louise Segan
Unravelling the side-dependent chemotherapy response of colorectal cancer using a patient-derived organoid model.
– Harrison Boka
Surgical Crossroads: How chronic kidney disease alters colorectal cancer surgery outcomes.
– Yajat Dua
Utilisation of the Cabrini Monash University Department of Surgery Tissue Microarray platform in collaborative research projects.
– Christine Georges
A comparison of surgery alone versus surgery plus adjuvant chemotherapy in stage III colon cancer: Utilisation of tissue microarrays to elucidate BRAF and dMMR status in understanding real-world patient cohorts and outcomes.
– Christine Georges
The survival paradox – comparing prognostic outcomes in patients with late stage II and early stage III colorectal cancer.
– Arthavan Surendran
A clinician-friendly dynamic nomogram to evaluate the obesity paradox in colorectal cancer survival outcomes.
– Simon Wilkins
Does BMI influence adverse postoperative outcomes following colorectal cancer surgery?
– Simon Wilkins
Rational engineering and design of 3D printed meshes for biofunctional assessment for pelvic reconstructive surgery: A pre-clinical assessment.
– David Hennes
Regenerative potential of human endometrial mesenchymal stem cells in sheep with simulated vaginal birth injury.
– David Hennes
Foreign body response to implanted human fascial lata in a mouse model: Implications for enhancing pelvic reconstructive surgery.
– Shayanti Mukherjee
Pre-hospital extracorporeal cardiopulmonary resuscitation: models of care and a narrative review.
– Karim Khalil and Ethan Erikson
Australian healthcare workers’ perspectives, practices, and perceived barriers to a more sustainable health system: a cross-sectional survey.
– Philip Russo
Perioperative nursing shortages: An integrative review of their impact, causal factors, and mitigation strategies.
– Ada Xie
Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trial.
– Philip Russo
Impact of receiving guideline concordant treatment on quality of life for people diagnosed with lung cancer: an Australian registry cohort study using patient-reported outcomes to drive value-based healthcare.
– Gary Richardson
Overall survival and patterns of care for women with rare ovarian cancers: A prospective study from the Australian National Gynae-Oncology Registry (NGOR).
– Gary Richardson
Patterns of ovarian cancer care and overall survival in Australia: A prospective study from the National Gynae-Oncology Registry (NGOR).
– Gary Richardson
Comparison of oxycodone SR and tapentadol SR in patients with CABG and/or valvular surgery.
– Seo Hyeon Jeong
Cancer-Induced Bone Pain: use of the Edmonton Classification System for Cancer Pain and Management of Refractory Pain.
– Merlina Sulistio
